Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) insider Bristol Investment Fund Ltd sold 1,150,000 shares of the stock in a transaction on Monday, September 18th. The shares were sold at an average price of $2.45, for a total value of $2,817,500.00. Following the completion of the sale, the insider now owns 1,432,108 shares of the company’s stock, valued at $3,508,664.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Research Solutions Stock Down 0.4 %
RSSS traded down $0.01 during trading on Tuesday, reaching $2.49. 18,218 shares of the stock traded hands, compared to its average volume of 26,873. The stock has a market capitalization of $73.46 million, a PE ratio of 125.06 and a beta of 0.56. The stock’s 50-day moving average is $2.20 and its 200 day moving average is $2.13. Research Solutions, Inc. has a 12 month low of $1.80 and a 12 month high of $2.65.
Research Solutions (NASDAQ:RSSS – Get Free Report) last released its quarterly earnings data on Wednesday, September 13th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. The company had revenue of $9.96 million for the quarter, compared to analysts’ expectations of $9.70 million. Research Solutions had a net margin of 1.52% and a return on equity of 9.88%. During the same quarter in the prior year, the firm earned ($0.02) EPS. As a group, equities research analysts anticipate that Research Solutions, Inc. will post -0.04 EPS for the current year.
Hedge Funds Weigh In On Research Solutions
Analyst Ratings Changes
A number of research firms recently weighed in on RSSS. Maxim Group restated a “buy” rating and issued a $5.00 price objective on shares of Research Solutions in a report on Thursday, September 14th. Roth Mkm reaffirmed a “buy” rating and set a $4.35 price target on shares of Research Solutions in a research report on Thursday, September 14th.
About Research Solutions
Research Solutions, Inc, through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle.
- Five stocks we like better than Research Solutions
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hold-It-Forever AutoZone Pulls into Buy Zone
- How to Find Cloud Software Company Stocks to Trade and Invest
- Virtual Riches: 3 Stocks Leading the VR Revolution
- How to Invest in Energy
- 5 eCommerce Companies that need to be on Your Watch List
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.